204 related articles for article (PubMed ID: 19239024)
1. [Advances in the study of the microbial efflux pumps and its inhibitors development].
Long QX; Zhou PF; Wu ZH; Wang HH; Xie JP
Yao Xue Xue Bao; 2008 Nov; 43(11):1082-8. PubMed ID: 19239024
[TBL] [Abstract][Full Text] [Related]
2. Bacterial efflux systems and efflux pumps inhibitors.
Marquez B
Biochimie; 2005 Dec; 87(12):1137-47. PubMed ID: 15951096
[TBL] [Abstract][Full Text] [Related]
3. Inhibitors of multidrug resistant efflux systems in bacteria.
Zechini B; Versace I
Recent Pat Antiinfect Drug Discov; 2009 Jan; 4(1):37-50. PubMed ID: 19149695
[TBL] [Abstract][Full Text] [Related]
4. [The importance of efflux systems in antibiotic resistance and efflux pump inhibitors in the management of resistance].
Aygül A
Mikrobiyol Bul; 2015 Apr; 49(2):278-91. PubMed ID: 26167829
[TBL] [Abstract][Full Text] [Related]
5. New Roads Leading to Old Destinations: Efflux Pumps as Targets to Reverse Multidrug Resistance in Bacteria.
Spengler G; Kincses A; Gajdács M; Amaral L
Molecules; 2017 Mar; 22(3):. PubMed ID: 28294992
[TBL] [Abstract][Full Text] [Related]
6. [Inhibition of pump and permeability mechanisms].
Sánchez P; Alonso A; Martínez JL
Rev Esp Quimioter; 1999 Jun; 12(2):116-9. PubMed ID: 10562671
[TBL] [Abstract][Full Text] [Related]
7. Multidrug-resistance efflux pumps - not just for resistance.
Piddock LJ
Nat Rev Microbiol; 2006 Aug; 4(8):629-36. PubMed ID: 16845433
[TBL] [Abstract][Full Text] [Related]
8. Estimation of efflux mediated multi-drug resistance and its correlation with expression levels of two major efflux pumps in mycobacteria.
Gupta AK; Chauhan DS; Srivastava K; Das R; Batra S; Mittal M; Goswami P; Singhal N; Sharma VD; Venkatesan K; Hasnain SE; Katoch VM
J Commun Dis; 2006 Mar; 38(3):246-54. PubMed ID: 17373356
[TBL] [Abstract][Full Text] [Related]
9. An overview of bacterial efflux pumps and computational approaches to study efflux pump inhibitors.
Jamshidi S; Sutton JM; Rahman KM
Future Med Chem; 2016; 8(2):195-210. PubMed ID: 26824720
[TBL] [Abstract][Full Text] [Related]
10. [Active efflux as the multidrug resistance mechanism].
Wasaznik A; Grinholc M; Bielawski KP
Postepy Hig Med Dosw (Online); 2009 Apr; 63():123-33. PubMed ID: 19373193
[TBL] [Abstract][Full Text] [Related]
11. [The role of cell wall organization and active efflux pump systems in multidrug resistance of bacteria].
Hasdemir U
Mikrobiyol Bul; 2007 Apr; 41(2):309-27. PubMed ID: 17682720
[TBL] [Abstract][Full Text] [Related]
12. Antibiotic Adjuvants: Make Antibiotics Great Again!
Douafer H; Andrieu V; Phanstiel O; Brunel JM
J Med Chem; 2019 Oct; 62(19):8665-8681. PubMed ID: 31063379
[TBL] [Abstract][Full Text] [Related]
13. Bacterial multidrug efflux pumps: mechanisms, physiology and pharmacological exploitations.
Sun J; Deng Z; Yan A
Biochem Biophys Res Commun; 2014 Oct; 453(2):254-67. PubMed ID: 24878531
[TBL] [Abstract][Full Text] [Related]
14. [Efflux pumps: their role in Staphylococcus aureus antibiotic resistance].
Doléans-Jordheim A; Michalet S; Bergeron E; Boisset S; Souard F; Dumontet C; Dijoux-Franca MG; Freney J
Ann Biol Clin (Paris); 2008; 66(5):499-508. PubMed ID: 18957338
[TBL] [Abstract][Full Text] [Related]
15. Bacterial resistance to antibiotics: active efflux and reduced uptake.
Kumar A; Schweizer HP
Adv Drug Deliv Rev; 2005 Jul; 57(10):1486-513. PubMed ID: 15939505
[TBL] [Abstract][Full Text] [Related]
16. Inhibitors of bacterial efflux pumps that also inhibit efflux pumps of cancer cells.
Amaral L; Spengler G; Martins A; Armada A; Handzlik J; Kiec-Kononowicz K; Molnar J
Anticancer Res; 2012 Jul; 32(7):2947-57. PubMed ID: 22753759
[TBL] [Abstract][Full Text] [Related]
17. Multidrug ABC transporters in bacteria.
Orelle C; Mathieu K; Jault JM
Res Microbiol; 2019; 170(8):381-391. PubMed ID: 31251973
[TBL] [Abstract][Full Text] [Related]
18. Understanding efflux in Gram-negative bacteria: opportunities for drug discovery.
Schweizer HP
Expert Opin Drug Discov; 2012 Jul; 7(7):633-42. PubMed ID: 22607346
[TBL] [Abstract][Full Text] [Related]
19. Inhibitors of efflux pumps in Gram-negative bacteria.
Pagès JM; Masi M; Barbe J
Trends Mol Med; 2005 Aug; 11(8):382-9. PubMed ID: 15996519
[TBL] [Abstract][Full Text] [Related]
20. Efflux systems in bacterial pathogens: an opportunity for therapeutic intervention? An industry view.
Lynch AS
Biochem Pharmacol; 2006 Mar; 71(7):949-56. PubMed ID: 16290174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
